In the current study, we have recapitulated the intricate nature of the TME by stimulating HR+/HER2− breast cancer cells with a selected complex of factors, representing the hormonal, inflammatory and growth stimulatory arms of the TME. The gene discussed is HR; the disease is breast carcinoma.